Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Fighting The Challenges Of Poverty
It is estimated that 1.4 billion people live in extreme poverty, on less than $2 a day. In 2000, 189 nations declared that they would "free all men, women, and children from the abject and dehumanizing conditions of extreme poverty". These nations signed up to Millennium Development Goals (MDGs) to combat poverty by 2015. To help meet these complex challenges and "make poverty history" more knowledge and evidence is needed. A launch event Wednesday 22nd July 2009 at the Department for International Development (DFID) marks a new phase of research collaboration between the Economic and Social Research Council (ESRC) and DFID which will provide more robust social science research to address poverty alleviation amongst the poorest countries and peoples of the world.

Personal Exposure Monitors Show Pharmacy Workers Inhale Drugs When Using Air Pressure-Activated Dispensing Machines
AlburtyLab released a report on its comprehensive evaluation of health risks for workers in pharmacies using air pressure-activated drug dispensing machines. The study tested pharmacy workers wearing personal exposure monitors (PEMs) while using the two leading types of air pressure-activated dispensing technologies - the McKesson/Parata Max and the McKesson/Parata RDS. This is the third major study conducted by AlburtyLab examining the issues relating to pharmacy worker exposure.
News of the day
Physical Activity In Children Improves Their Sleeping Patterns
A research published ahead of print in the Archives of Disease in Childhood reports that every hour of the day children are inactive adds three minutes to the time it takes them to fall asleep.
Nutrition

Cambridge Consultants To Showcase Inhaler Design And Development Process At RDD 2009, Europe

Cambridge Consultants will be showcasing its proprietary design and development process for Dry Power Inhalers (DPIs) at the Respiratory Drug Delivery (RDD) Europe 2009 conference in Lisbon later this month.÷  The company will demonstrate its ability to move inhaler design quickly through all stages of development from concept through manufacture to final product, getting it right first time, accelerating the creation of new inhalable drug delivery devices, and offering pharmaceutical companies a quick route to market, saving up to six months in development. "Our RDD presence is all about the importance of speed to market, and this demonstration is designed to highlight the range of development capabilities we can deploy to achieve it for our clients," commented David Blakey, Head of Drug Delivery at Cambridge Consultants.÷  "It is crucial to ensure process quality in stages such as concept creation, complex mathematical modelling and detailed design.÷  These are areas where Cambridge Consultants adds significant value, based on our skill and experience in running turn key developments, from concept to clinical trial and through transfer to manufacture." Cambridge Consultants will be using Gen-X, a proprietary DPI, to demonstrate the key stages in the design cycle.÷  The display tracks the stages of the process up to the test bed stage, where the efficacy of the de-aggregation engine has been tested.÷  Cambridge Consultants is currently selecting development partners to take this concept to market. David Blakey adds: "Supported by our proprietary design and development process, our partners can cut up to six months off the development cycle for DPIs, giving them a significant head start and reducing development risk." The demonstration of Cambridge Consultants" product development process will be available on Cambridge Consultants" stand at the Respiratory Drug Delivery Europe 2009 conference in Lisbon, Portugal, from 19-22 May. Cambridge Consultants


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009